Biocogniv logo

Biocogniv

Emerging

FDA Breakthrough Device-designated AI platform predicting sepsis mortality risk in emergency departments; $17.08M from Breyer Capital and YC generating $2.6M revenue at 13-person Burlington-based team.

40
AI Score
Grade C
AI Visibility Score (Beta)
HealthcareWebsiteUpdated October 2026

Company Overview

About Biocogniv

Biocogniv is a Burlington, Vermont-based clinical AI company that has developed an FDA Breakthrough Device Designation-granted platform for predicting sepsis-related mortality and ICU admission risk in emergency departments — using AI analysis of routine clinical data (vital signs, lab values, patient history) to identify patients at highest risk of deterioration hours before clinical signs become obvious to clinicians, enabling earlier intervention in one of healthcare's most time-sensitive conditions. Founded in 2019 and a Y Combinator W20 graduate, Biocogniv raised $17.08 million from Breyer Capital and YC, generating $2.6 million in revenue in 2024 with a 13-person team.

Business Model & Competitive Advantage

Biocogniv's algorithm analyzes the data already being collected in emergency departments — EHR data, nursing assessments, vital signs monitoring, laboratory results — to generate a continuous risk score that predicts which patients will develop sepsis-related complications requiring ICU admission within the next 6-12 hours. Unlike single-timepoint scoring systems (like SOFA or SIRS criteria), Biocogniv's model incorporates the trajectory of clinical data over time, enabling earlier detection of the subtle patterns that precede septic shock.

Competitive Landscape 2025–2026

In 2025, Biocogniv competes in the AI clinical decision support and sepsis detection market with Sepsis-prediction tools from Epic (Deterioration Index, built into Epic EHR), IBM Watson Health (Micromedex), and Philips (IntelliVue Guardian) for sepsis risk monitoring in acute care. Sepsis kills 270,000+ Americans annually and is the leading cause of in-hospital mortality — earlier detection and intervention directly reduces mortality. The FDA Breakthrough Device Designation accelerates the regulatory pathway and signals clinical significance. Breyer Capital's investment (known for healthcare technology) provides both capital and strategic credibility. The 2025 strategy focuses on expanding hospital contracts, completing the FDA clearance process to enable broader commercial deployment, and building the EHR integration partnerships with Epic and Cerner that scale adoption beyond manual API connections.

Founded
2019
Headquarters
Biocogniv is a Burlington, Vermont
Revenue
$2.6M
Curated content • Fact-checked and verified

Recent Activity

View all →

Key Differentiators

Emerging Innovator

Biocogniv is an emerging player bringing innovative solutions to the Healthcare market.

Frequently Asked Questions

Estimated Visibility Trend (Beta)

Simulated 8-week rolling score

40
→ Stable

Based on estimated brand signals. Historical tracking coming soon.

Similar Brands

S2 logo

S2

Developer Tools
B2bCloud NativeDeveloper ToolsInfrastructurePlatformSaas

S2 is an AI-powered security platform focused on vulnerability discovery and attack surface management for enterprise security teams. The company's platform combines automated scanning, AI-powered ana

athenahealth logo

athenahealth

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

athenahealth is a cloud-based electronic health records (EHR), medical billing, and practice management company founded in 1997 and headquartered in Watertown, Massachusetts. The company was built on

Epic Systems logo

Epic Systems

Healthcare
B2bCloud NativeEnterpriseErpHealthtechNorth AmericaSaas

Epic Systems Corporation was founded in 1979 by Judith Faulkner and is headquartered in Verona, Wisconsin, remaining privately held with Faulkner as majority owner. The company develops large-scale el

Pfizer logo

Pfizer

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The compan

Moderna logo

Moderna

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Moderna is a clinical-stage biotechnology company that pioneered the development of messenger RNA (mRNA) therapeutics and vaccines, founded in 2010 by Noubar Afeyan, Robert Langer, Kenneth Chien, Stép

Amgen logo

Amgen

Healthcare Tech
B2bHealthtechManufacturingSaasPublic

Amgen Inc. is one of the world's largest biotechnology companies, headquartered in Thousand Oaks, California. Founded in 1980 as Applied Molecular Genetics, Amgen pioneered the development of biologic

Compare Biocogniv with Competitors

Side-by-side AI visibility scores, platform breakdown, and market position.

For Biocogniv

Claim This Profile

Are you from Biocogniv? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.

Claim Biocogniv Profile →
For competitors & analysts

Track AI Visibility in Real Time

Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Biocogniv vs competitors. Get alerts when AI recommendations shift.

Start Free Tracking →